Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2015 19:00 ET | Source: biOasis Technologies Inc.

biOasis Provides Scientific Updates on Its Transcend Programs

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 12, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
April 21, 2015 17:00 ET | Source: biOasis Technologies Inc.

biOasis European Patent Granted for The Use of Transcend for the Delivery of Enzymes to Treat Lysosomal Storage Disease in The Brain

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
March 16, 2015 09:30 ET | Source: biOasis Technologies Inc.

biOasis Releases Results From an Ischemic Stroke Model with Transcend BBB Carrier Peptide (MTfp):MTfp-siRNA Reduces Both the Damage Caused by Infarct and Significantly Improves Neurological Score

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 16, 2015) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
January 30, 2015 20:30 ET | Source: biOasis Technologies Inc.

biOasis Announces Grant of Stock Options

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2015) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF) (the "Company") wishes to announce that it has granted an aggregate...
January 20, 2015 17:24 ET | Source: biOasis Technologies Inc.

biOasis Announces the Release of an Analyst Report

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF)(the "Company") wishes to announce the release of an analyst report...
October 07, 2014 09:30 ET | Source: biOasis Technologies Inc.

biOasis Engages Willow Tree Group to Assist with Global Business Development Activities

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 7, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF) (TSX VENTURE:BTI), the pioneering biopharmaceutical company focused on the delivery of...
September 18, 2014 09:30 ET | Source: biOasis Technologies Inc.

biOasis Initiates MPS II Study with Renowned Lysosomal Storage Disease Expert Dr. Maurizio Scarpa and The Brains for Brain Foundation

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 18, 2014) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), the pioneering biopharmaceutical company focused on the delivery of...
September 09, 2014 09:30 ET | Source: biOasis Technologies Inc.

biOasis Advances Its Lysosomal Storage Disease Program with a Knockout Model for Sandhoff Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 9, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), announces the commencement of a new phase of its Lysosomal Storage...
September 04, 2014 09:00 ET | Source: biOasis Technologies Inc.

biOasis Announces NSERC Grant to the University of British Columbia in Support of Collaborative R&D Work with biOasis

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 4, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), announces that the Natural Sciences and Engineering Research Council...
August 29, 2014 17:43 ET | Source: biOasis Technologies Inc.

biOasis Closes Non-Brokered Private Placement for $1,609,753.15 Gross Proceeds

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 29, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF) (the "Company") is please to announce it has closed its non-brokered...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right